Home / Import refusals / AEK-7907640-0/40002/1

FDA Import Refusal AEK-7907640-0/40002/1 — TAGI Pharma, Inc.

TAGI Pharma, Inc. — FEI 3010167068

The FDA refused shipment AEK-7907640-0/40002/1 from TAGI Pharma, Inc. (United States) on November 12, 2025. The refused product falls under Drugs and Biologics — RIVAROXABAN. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 12, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61LDA42 RIVAROXABAN
Charges
75

Recent inspections

  • 1231414 (VAI Thu Jun 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1036765 (NAI Wed Dec 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-7907640-0/20003/1 (Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7907640-0/50002/1 (Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7907640-0/30002/1 (Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7907640-0/60002/1 (Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7907640-0/10001/1 (Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources